Pictet Asset Management Holding Sa Bridge Bio Pharma, Inc. Transaction History
Pictet Asset Management Holding Sa
- $88 Billion
- Q3 2024
A detailed history of Pictet Asset Management Holding Sa transactions in Bridge Bio Pharma, Inc. stock. As of the latest transaction made, Pictet Asset Management Holding Sa holds 2,803,057 shares of BBIO stock, worth $74.6 Million. This represents 0.08% of its overall portfolio holdings.
Number of Shares
2,803,057
Previous 2,648,957
5.82%
Holding current value
$74.6 Million
Previous $67.1 Million
6.36%
% of portfolio
0.08%
Previous 0.08%
Shares
5 transactions
Others Institutions Holding BBIO
# of Institutions
291Shares Held
171MCall Options Held
10.4MPut Options Held
2.37M-
Kohlberg Kravis Roberts & Co. L.P. New York, NY25.3MShares$672 Million35.94% of portfolio
-
Viking Global Investors LP25.1MShares$668 Million2.47% of portfolio
-
Vanguard Group Inc Valley Forge, PA14.2MShares$378 Million0.01% of portfolio
-
Black Rock Inc. New York, NY12.4MShares$331 Million0.01% of portfolio
-
Aisling Capital Management LP New York, NY6.07MShares$161 Million63.58% of portfolio
About BridgeBio Pharma, Inc.
- Ticker BBIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 148,246,000
- Market Cap $3.94B
- Description
- BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...